Analyses of HNSCC microarrays (GSE31056) and Genotype-Tissue Expression (GTEx) datasets indicated significantly higher c-Met expression levels in patients with HNSCC (left panel, Figure 1A), and this higher c-Met expression predicted significantly lower overall survival (OS, middle panel, Figure 1A) and disease-free survival (DFS, right panel, Figure 1A) rates. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.